vimarsana.com

Page 3 - உயிர் அறிவியல் முதலீட்டாளர் தொடர்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Harmony Biosciences To Present WAKIX® (pitolisant) Efficacy and Safety Data at Upcoming 2021 American Psychiatric Association Annual Meeting

Harmony Biosciences Announces Date of First Quarter 2021 Financial Results

Harmony Biosciences Announces Date of First Quarter 2021 Financial Results News provided by Share this article Share this article PLYMOUTH MEETING, Pa., April 27, 2021 /PRNewswire/ Harmony Biosciences Holdings, Inc. ( Harmony or the Company ) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare, neurological disorders who have unmet medical needs, today announced that it will issue a press release on the Company s first quarter 2021 financial results on Tuesday, May 11, 2021 at 8:00 a.m. ET. Following the release, Harmony will conduct a conference call and live webcast on the same day, at 8:30 a.m. ET. To participate in the call, please dial (833) 614-1471 (domestic) or +1 (914) 987-7209 (international), and reference passcode 2269379. It is recommended that you dial in at least 10 minutes prior to the call.

Harmony Biosciences To Present WAKIX® (pitolisant) Efficacy and Safety Data at Upcoming 2021 American Psychiatric Association Annual Meeting

Harmony Biosciences To Present WAKIX® (pitolisant) Efficacy and Safety Data at Upcoming 2021 American Psychiatric Association Annual Meeting
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Harmony Biosciences Launches Grant Program To Address Inequities In The Delivery Of Healthcare In Patients With Sleep Disorders

Harmony Biosciences Launches Grant Program To Address Inequities In The Delivery Of Healthcare In Patients With Sleep Disorders Progress at the Heart grant program will award up to $125,000 in grants in recognition of World Health Day and National Minority Health Month News provided by Share this article Share this article PLYMOUTH MEETING, Pa., April 7, 2021 /PRNewswire/  Harmony Biosciences Holdings, Inc. ( Harmony ) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs, today announced the launch of a new grant program, Progress at the Heart, to accelerate programs and solutions that address inequity in access to diagnosis, treatment, and care in the rare disease and sleep disorder community.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.